Kenvue INC 8-K filings

Kenvue Inc. announced its second quarter 2026 financial results, showcasing a third consecutive quarter of net and organic sales growth, with diluted EPS rising 9% to $0.24.

Kenvue Inc. shareholders elected all 12 director nominees, approved executive compensation, and ratified auditors at the 2026 Annual Meeting.

Kenvue Inc. announced first quarter 2026 financial results, showing a 4.5% increase in net sales and a significant 47% rise in diluted EPS.

Kenvue Inc. announces the appointment of Heather Howlett as interim Chief Financial Officer, effective May 12, 2026, following the departure of Amit Banati.

Kenvue Inc. announced that Chief Financial Officer Amit Banati will step down effective May 12, 2026, to become a CEO at another company, with an interim successor planned.

Kenvue Inc. stockholders overwhelmingly approved the merger agreement with Kimberly-Clark Corporation, moving closer to forming a global health and wellness leader.

Kenvue Inc. has filed an 8-K to supplement its merger proxy statement with Kimberly-Clark Corporation, addressing multiple shareholder litigations and providing updated financial analysis.

Kimberly-Clark Corporation announced an agreement to acquire Kenvue Inc. for approximately $48.7 billion in a cash and stock transaction, creating a global health and wellness leader.

Kenvue reported a 3.5% net sales decrease in Q3 2025, affirmed its full-year outlook, and announced Kirk Perry as permanent CEO alongside a definitive merger agreement with Kimberly-Clark.

Kenvue Inc. reported a 4.0% decline in second-quarter net sales and revised its full-year 2025 outlook downwards, while continuing its strategic alternatives review.

Kenvue Inc. announced a leadership transition with the departure of CEO Thibaut Mongon and the appointment of Kirk Perry as interim CEO, alongside a comprehensive strategic review and preliminary second-quarter 2025 financial results showing a sales decline.

Kenvue Inc. has announced a significant leadership change in its Asia Pacific division, with Ellie Bing Xie departing and Anindya (Andy) Dasgupta appointed as the new Group President, effective July 14, 2025.

Kenvue Inc. announced the results of its 2025 Annual Meeting of Shareholders, confirming the election of all 13 director nominees, the non-binding approval of named executive officer compensation, and the ratification of PricewaterhouseCoopers LLP as its independent auditor.

Kenvue Inc. successfully closes a $750 million offering of 4.850% Senior Notes due in 2032, planning to use the proceeds for general corporate purposes.

Kenvue Inc. has entered into an underwriting agreement to issue and sell $750 million in senior notes due 2032 in a public offering.

Kenvue reports a slight decrease in net sales for Q1 2025, appoints Amit Banati as CFO, and updates its full-year outlook to reflect tariff costs and currency impacts.

Kenvue Inc. and Starboard Value LP enter into a cooperation agreement, resulting in the immediate appointment of three new directors to Kenvue's Board.

Kenvue's Q4 net sales decreased slightly by 0.1% to $3.7 billion, while full-year net sales increased by 0.1% to $15.5 billion, with the company providing its financial outlook for 2025.

Kenvue's third-quarter results show a slight decrease in net sales but an expansion in gross profit margins, driven by efficiency gains and strategic reinvestment.

Kenvue's second quarter saw a slight decrease in net sales but experienced organic growth, alongside a significant non-cash impairment charge related to its Dr.Ci:Labo business.

Kenvue Inc. has announced the resignation of two board members and the appointment of two new directors, effective on various dates in 2024.

Kenvue Inc. successfully held its 2024 Annual Meeting of Shareholders, electing all director nominees and approving executive compensation matters.

Kenvue reported a 1.1% increase in net sales for Q1 2024 and announced a multi-year restructuring plan to optimize costs.

Kenvue's full year 2023 saw a 3.3% increase in net sales, while the fourth quarter experienced a 2.7% decrease, with the company providing a mixed outlook for 2024.